SW · SFZN.SW
Siegfried Holding AG
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Zofingen 4800
- Website
- siegfried.ch
Price · as of 2025-12-31
$78.70
Market cap 3.68B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $50.95 | -35.26% |
| Intrinsic Value(DCF) | $33.62 | -57.28% |
| Graham-Dodd Method(GD) | $39.35 | -50% |
| Graham Formula(GF) | $40.92 | -48% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $8.25 | $37.60 | $0.00 | $11.38 | $3.23 |
| 2012 | $11.05 | $31.96 | $0.00 | $10.10 | $11.41 |
| 2013 | $14.79 | $29.14 | $1.25 | $14.47 | $13.79 |
| 2014 | $13.15 | $37.22 | $1.83 | $12.58 | $0.00 |
| 2015 | $17.58 | $28.65 | $2.21 | $15.13 | $57.61 |
| 2016 | $23.24 | $29.44 | $100.59 | $17.89 | $39.78 |
| 2017 | $33.52 | $30.99 | $129.50 | $18.87 | $12.54 |
| 2018 | $34.83 | $33.56 | $46.49 | $19.47 | $18.50 |
| 2019 | $32.97 | $31.18 | $0.00 | $13.04 | $16.59 |
| 2020 | $74.04 | $49.82 | $0.00 | $15.09 | $13.90 |
| 2021 | $78.68 | $57.34 | $10.90 | $21.32 | $84.58 |
| 2022 | $64.21 | $53.73 | $31.25 | $30.57 | $71.28 |
| 2023 | $91.28 | $58.46 | $0.00 | $27.98 | $30.29 |
| 2024 | $89.12 | $70.51 | $0.13 | $35.96 | $36.59 |
| 2025 | $84.00 | $50.95 | $0.60 | $39.35 | $40.92 |
AI valuation
Our deep-learning model estimates Siegfried Holding AG's (SFZN.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $50.95
- Current price
- $78.70
- AI upside
- -35.26%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$33.62
-57.28% upside
Graham-Dodd
$39.35
-50% upside
Graham Formula
$40.92
-48% upside
About Siegfried Holding AG
Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
- CEO
- Marcel Imwinkelried
- Employees
- 3.89K
- Beta
- 0.80
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($33.62 ÷ $78.70) − 1 = -57.28% (DCF, example).